Park Medi World Limited (NSE:PARKHOSPS) filed a Regulation 30 disclosure on 4 August 2026 confirming that the audio recording of its Earnings Conference Call, held the same day to discuss unaudited standalone and consolidated financial results for the quarter ended 30 June 2026, has been made available on the company's investor relations webpage.
Key Highlights
- The earnings conference call was held on 4 August 2026 to discuss unaudited Q1 FY27 standalone and consolidated financial results for the quarter ended 30 June 2026.
- Park Medi World (NSE:PARKHOSPS) filed the disclosure under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
- The audio recording of the call has been published on the company's official investor relations section, accessible to all shareholders and market participants.
- The filing was signed by Abhishek Kapoor, designated as Company Secretary and Compliance Officer, on behalf of Park Medi World Limited.
About the Company
Park Medi World Limited, listed on the NSE under the ticker PARKHOSPS and headquartered in India, operates in the healthcare and hospital services sector. The company runs the Park Hospital group, which provides multi-specialty medical care across several facilities in northern India, offering services spanning surgery, diagnostics, emergency care, and allied clinical disciplines.
Announcement in Detail
The filing submitted to BSE Limited and the National Stock Exchange of India on 4 August 2026 states that the Earnings Conference Call was convened on that date to review the unaudited standalone and consolidated financial results for the first quarter of FY27, covering the period ended 30 June 2026. The disclosure was made pursuant to Regulation 30 of the SEBI Listing Regulations, which requires listed companies to promptly inform exchanges of material developments, including investor communication events such as analyst and institutional investor calls.
In keeping with standard practice for such disclosures, Park Medi World confirmed that the audio recording of the call has been hosted on its investor relations portal, ensuring that retail shareholders, institutional investors, and analysts who were unable to participate in real time retain access to the same information presented during the session. The compliance filing was executed and submitted by Abhishek Kapoor, the designated Company Secretary and Compliance Officer, acting on behalf of the company's board.
Impact on Investors
Investors will note that the publication of the audio recording supports equal access to management commentary for all shareholders, regardless of whether they attended the live call. The filing shows the company is fulfilling its continuous disclosure obligations under SEBI's Listing Regulations, which is a standard compliance requirement for listed entities. Shareholders will observe that the underlying financial results discussed, covering the standalone and consolidated performance for Q1 FY27, remain unaudited at the time of this filing, and the company has not disclosed specific revenue, profit, or margin figures within this particular Regulation 30 intimation.
Sector / Market Context
India's private hospital and healthcare services industry has seen sustained capacity expansion over the past several years, with the sector drawing interest from both domestic and foreign institutional investors. SEBI's Regulation 30 framework, which mandates timely disclosure of analyst and investor communication events, is designed to uphold market transparency and reduce information asymmetry between institutional participants and retail shareholders across all listed companies in this space.